Survey on the knowledge and use of the Jext prescriber’s checklist among physicians – a post-authorisation safety study (XX-JX-01)

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS29289
• Study ID:
  32970
• Official title and acronym:
  Survey on the knowledge and use of the Jext prescriber’s checklist among physicians – a post-authorisation safety study (XX-JX-01)
• DARWIN EU® study:
  No
• Study countries:
  Ireland
• Study description:
  No information provided.
• Study status:
  Finalised

Research institutions and networks

Institutions

ALK-Abelló

Study timelines

Date when funding contract was signed

Actual:18/12/2018

Study start date

Planned:01/06/2019

Actual:11/04/2019

Data analysis start date

Actual:26/06/2019

Date of final study report

Planned:01/12/2019

Actual:17/09/2019

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

ALK-Abelló A/S

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)